Intranasal monoclonal antibodies (mAbs) offer a promising cost-reducing and non-invasive alternative to systemic administration. Intranasal palivizumab prevented respiratory syncytial virus (RSV) ...

Although immunization through vaccination is one of the most successful public health interventions, coverage of some vaccination programs has decreased in recent years due to increased vaccine ...

For more than three decades, researchers Christine Stabell Benn and Peter Aaby from the Bandim Health Project have conducted randomized trials involving thousands of children in Guinea-Bissau and ...

As cell and gene therapies (CGTs) continue to advance, they have unique developmental features that may require innovation in ...

A landmark Lancet analysis of more than 150,000 trial participants challenges decades of statin side-effect warnings and calls for updated drug labels grounded in randomized evidence. Study: ...